TGen and HonorHealth Research Institute Clinical Trial Report High Rate of Tumor Shrinkage Among Patients With Advanced Pancreatic Cancer
April 25, 2017 Edited For Style and Length Results of the “Triplet Clinical Trial” at HonorHealth Institute is based on the TGen “Triple Research” is presented at ASCO-GI symposium in
Dr. Daniel Von Hoff, TGen ‘s World Renowned Physician-in-Chief Honored By Columbia University For Excellence in Clinical Medicine
May 8, 2017 Edited For Style and Space Dr. Daniel Von Hoff – Distinguished Professor, Physician-In-Chief, and Director of Molecular Medicine at the Translational Genomics Research Institute (TGen) – will
STUDY SHOWS ‘SOFTENING’ OF PANCREATIC CANCER TUMORS BEFORE CHEMO MARKEDLY IMPROVES PATIENT SURVIVAL
April 6, 2017 Source: Garvan Institute of Medical Research Australia Edited For Style and Length Australian scientists have uncovered a promising new approach to treating pancreatic cancer. By targeting tissue
SCIENTISTS AT TEL AVIV UNIVERSITY DISCOVER MECHANISM THAT CAUSES CANCER CELLS TO SELF-DESTRUCT
March 27, 2017 Source: American Friends of Tel Aviv University Edited For Style and Length Modifying specific proteins during cancer cell division unleashes a natural killing mechanism, say Tel Aviv
LIGHT SCATTERING TOOL HELPS DOCTORS IDENTIFY EARLY PANCREATIC CANCER
March 13, 2017 Source: Beth Israel Deaconess Medical Center Edited For Style and Length The New Optical Tool Can Predict Malignant Potential of Pancreatic Cysts With 95% Accuracy Compared To
TWO MIGRATION PROTEINS BOOST PREDICTIVE PANCREATIC CANCER BIOMARKER
February 28, 2017 Source: MD Anderson Edited For Style and Length A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. A Combination of Blood Markers Improves Detection in
OUR GOAL IS TO TRIPLE THE AVERAGE 5-YEAR PANCREATIC CANCER SURVIVAL RATE
Written By Tony Subia March 2, 2017 Updated October 6, 2018 Pancreatic Cancer is the Most Brutal of Cancers For decades the average 5-year average survival rate for cancer of
DISCOVERY OF DISTINCT CELL SUB-TYPES AROUND TUMORS HELPS EXPLAIN WHY PANCREATIC CANCER IS SO HARD TO TREAT
February 24, 2017 Source: Cold Springs Harbor Laboratory Edited For Style and Length Distinct cellular subtypes in dense tumor-enveloping stroma may be precisely targeted to improve treatment response Researchers have
Study Suggests Controlling Genes Which Lead To Metastatic Pancreatic Cancer May Stop The Cancer From Spreading
January 16. 2017 Source: Johns Hopkins Medicine Edited For Style and Length Epigenetic Changes, Not DNA Mutations, May Drive Some Metastasis. Epigenetics is the study of biological mechanisms that switch
TYPE 2 ONSET DIABETES CAN BE AN EARLY WARNING SIGN OF PANCREATIC CANCER
January 29, 2017 Source: European Cancer Organization Edited For Style, Length, and Insight NOTE: The following study was performed by researchers from the Prevention Research Institute in Lyon, France and
“Pursuing The Scar”: Latest State of Pancreatic Cancer Research By Dr. Daniel Von Hoff
Video Produced By: Robert Rogers December 2016 A Must Watch: Astounding New Discoveries in Pancreatic Cancer Treatment “Pursuing The Scar” presentation by Dr. Daniel Von Hoff at the 2016 14th